| Etoricoxib impurity Q |
依托考昔杂质Q |
292067-97-1 |
| Propoxyphenyl Sildenafil |
丙氧基苯基西地那非 |
877777-10-1 |
| Nintedanib impurity G |
尼达尼布杂质G |
894783-61-0 |
| Desonide 1,2-Saturated |
地奈德1,2饱和 |
638-93-7 |
| 2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine |
依托考昔杂质P |
307531-96-0 |
| 1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
沃替西汀杂质C |
1293489-74-3 |
| Etoricoxib Impurity 8 |
依托考昔杂质 8 |
1421227-97-5 |
| Losartan Impurity 7 |
5-(4-(二溴甲基)-[1,1-二联苯]-2-基)-1-三苯甲基-1H-四唑 |
358685-13-9 |
| 2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
替格瑞洛杂质21 |
1858267-99-8 |
| Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
卡博替尼杂质3 |
145591-80-6 |
| Vortioxetine Impurity 4 |
沃替西汀杂质4 |
1293489-77-6 |
| 4-[(1-Carboxy-1-methylethyl)amino]-2-fluorobenzoic acid |
4-[(1-Carboxy-1-methylethyl)amino]-2-fluorobenzoic acid |
1332524-02-3 |
| 4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
替格瑞洛杂质30 |
1823431-32-8 |
| (R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
曲格列汀杂质 |
1812193-01-3 |
| Epiprednisolone |
泼尼松龙EP杂质F |
600-90-8 |
| Dabigatran Etexilate iMpurity 1 |
达比加群酯杂质1 |
1610758-19-4 |
| Desonide delta 9 (11) analog |
地奈德Δ9(11)类似物 |
5541-37-7 |
| Aztreonam Impurity B |
氨曲南杂质B |
102586-36-7 |
| Desoxymetasone 21-Acetate |
地塞米松酮杂质G |
1597-78-0 |
| 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 11,21-diacetate |
9-氟-11BETA,17,21-三羟基-16ALPHA-甲基孕甾-1,4-二烯-3,20-二酮 11,21-二乙酸酯 |
3949-26-6 |
QQ
微信
